Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-28

Clinical Trial Update: ICI-VPH: Impact of HPV Immunisation Schedules Against HPV [Phase 3]

View source ↗

Summary

Phase 3 trial update on the impact of HPV vaccination schedules on outcomes related to Human Papillomavirus infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: CHU de Quebec-Universite Laval | Conditions: Human Papillomavirus Infections | Phase 3 | Status: COMPLETED